Web Exclusives

FDA approves new drugs

On Sept. 2, the U.S. Food and Drug Administration (FDA) approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting. Read more. On…

Racial bias in health care

On Aug. 11, JAMA published “Racial Bias in Health Care and Health: Challenges and Opportunities.” Read the viewpoint.

Risk/benefit ratio for statins

A study in the American Journal of Physiology—Cell Physiology highlights the importance of weighing risk with benefits when considering statins as a preventive measure.…

FDA approves new drugs

On Sept. 2, the U.S. Food and Drug Administration (FDA) approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting. Read…

Racial bias in health care

On Aug. 11, JAMA published “Racial Bias in Health Care and Health: Challenges and Opportunities.” Read the viewpoint.

Risk/benefit ratio for statins

A study in the American Journal of Physiology—Cell Physiology highlights the importance of weighing risk with benefits when considering statins as a…

Test Your Knowledge

Cannabis TYK

Which of the following best explains why clinicians face challenges in discussing medicinal marijuana with their patients?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.